Neopride Pharmaceuticals Limited
About Neopride Pharmaceuticals Limited
Data last updated:
Neopride Pharmaceuticals Limited is a public limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74140AP2013PLC086653. Its GSTIN is 37AAECN3023B1Z1 (Andhra Pradesh).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.55 Cr. It is led by directors including Goluguri Ramakrishna Reddy and Goluguri Sri Rama Reddy.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at H.No. 48 – 15 – 7 Sai Paradise Apartments Srinagar Dwaraka Nagar, Visakhapatnam, Andhra Pradesh, India – 530016.
Court records list 32 cases involving the company, including 20 filed by the company and 12 filed against it; 10 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Neopride Pharmaceuticals Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. 48 – 15 – 7 Sai Paradise Apartments Srinagar Dwaraka Nagar, Visakhapatnam, Andhra Pradesh, India – 530016
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Neopride Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Neopride Pharmaceuticals Limited
FY 2021 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neopride Pharmaceuticals Limited, buy the company report.
Board of directors of Neopride Pharmaceuticals Limited
Neopride Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Goluguri Ramakrishna Reddy Also directs: Nutrient Marine Foods Limited, Nancy Industries Limited | Director | 26 Mar 2013 | 13 Years 7 Months | Current |
| Goluguri Sri Rama Reddy | Director | 26 Mar 2013 | 13 Years 7 Months | Current |
| Goluguri Venkata Reddy | Director | 26 Mar 2013 | 13 Years 7 Months | Current |
Auditor
Neopride Pharmaceuticals Limited is audited by SATYANARAYANA RAJU & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SATYANARAYANA RAJU & CO | FY 2019 | 007527S |
Shareholding
The shareholding of Neopride Pharmaceuticals Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Neopride Pharmaceuticals Limited, buy the company report.
Legal cases
Neopride Pharmaceuticals Limited has 32 court cases on record: 20 filed by Neopride Pharmaceuticals, 12 filed against it. 10 cases are pending and 22 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 20 | 0 | 5 |
| Supreme Court | 12 | 12 | 5 |
Cases on record (5 of 32)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0801-Benami Transaction Act : Benami Transaction Act) | Filed against the company by The Asst. Commissioner of Income Tax and 1 other | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against The Adjudicating Authority and 3 others | Pending |
| Supreme Court | Court case | Filed against the company by Union of India | Pending |
| Supreme Court | Court case | Filed against the company by The Adjudicating Authority | Pending |
| Supreme Court | Court case | Filed against the company by Assistant Commissioner of Income Tax(Initiating Officer) Benami Transactions Prohibition Unit Hyderabad | Pending |
To see the full case history of Neopride Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neopride Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neopride Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAECN3023B1Z1 | Andhra Pradesh | Active | 23 Aug 2018 |
To see the full GST registrations and return filing status of Neopride Pharmaceuticals Limited, buy the company report.
Recent activity
Neopride Pharmaceuticals Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Raja Sekhara Reddy Tetali ceased to be Director on 17 Jul 2020.
Frequently asked questions
Neopride Pharmaceuticals is an active public limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 March 2013 (13+ years old) and is registered under CIN U74140AP2013PLC086653.
Neopride Pharmaceuticals has 3 current directors:
- Goluguri Ramakrishna Reddy - Director
- Goluguri Sri Rama Reddy - Director
- Goluguri Venkata Reddy - Director
The latest financial statements of Neopride Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Neopride Pharmaceuticals is 37AAECN3023B1Z1, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Neopride Pharmaceuticals is U74140AP2013PLC086653. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neopride Pharmaceuticals has 32 court cases on record: 20 filed by the company and 12 filed against it. 10 are pending. Most are in the high courts.
Neopride Pharmaceuticals was incorporated on 26 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Vijayawada.
Raja Sekhara Reddy Tetali ceased to be Director on 17 Jul 2020. Goluguri Ramakrishna Reddy was appointed as Director on 26 Mar 2013. Goluguri Sri Rama Reddy was appointed as Director on 26 Mar 2013. Neopride Pharmaceuticals has 4 board changes on record in total.
The registered office of Neopride Pharmaceuticals is at H.No. 48 – 15 – 7 Sai Paradise Apartments Srinagar Dwaraka Nagar, Visakhapatnam, Andhra Pradesh, India – 530016.
Neopride Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.